These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30958370)

  • 21. Mutation profile of APP, PSEN1, and PSEN2 in Chinese familial Alzheimer's disease.
    Gao Y; Ren RJ; Zhong ZL; Dammer E; Zhao QH; Shan S; Zhou Z; Li X; Zhang YQ; Cui HL; Hu YB; Chen SD; Chen JJ; Guo QH; Wang G
    Neurobiol Aging; 2019 May; 77():154-157. PubMed ID: 30822634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double Mutations in a Patient with Early-Onset Alzheimer's Disease in Korea: An
    Bae H; Shim KH; Yoo J; Yang YS; An SSA; Kang MJ
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery and validation of autosomal dominant Alzheimer's disease mutations.
    Hsu S; Gordon BA; Hornbeck R; Norton JB; Levitch D; Louden A; Ziegemeier E; Laforce R; Chhatwal J; Day GS; McDade E; Morris JC; Fagan AM; Benzinger TLS; Goate AM; Cruchaga C; Bateman RJ; ; Karch CM
    Alzheimers Res Ther; 2018 Jul; 10(1):67. PubMed ID: 30021643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two Novel Mutations in the First Transmembrane Domain of Presenilin1 Cause Young-Onset Alzheimer's Disease.
    Liu CY; Ohki Y; Tomita T; Osawa S; Reed BR; Jagust W; Van Berlo V; Jin LW; Chui HC; Coppola G; Ringman JM
    J Alzheimers Dis; 2017; 58(4):1035-1041. PubMed ID: 28550247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the Alzheimer's Disease Mutations AβPP695sw and PSEN1M146I in Double-Transgenic Göttingen Minipigs.
    Jakobsen JE; Johansen MG; Schmidt M; Liu Y; Li R; Callesen H; Melnikova M; Habekost M; Matrone C; Bouter Y; Bayer TA; Nielsen AL; Duthie M; Fraser PE; Holm IE; Jørgensen AL
    J Alzheimers Dis; 2016 Jul; 53(4):1617-30. PubMed ID: 27540966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computing the Pathogenicity of Alzheimer's Disease Presenilin 1 Mutations.
    Tang N; Dehury B; Kepp KP
    J Chem Inf Model; 2019 Feb; 59(2):858-870. PubMed ID: 30681848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aβ profiles generated by Alzheimer's disease causing PSEN1 variants determine the pathogenicity of the mutation and predict age at disease onset.
    Petit D; Fernández SG; Zoltowska KM; Enzlein T; Ryan NS; O'Connor A; Szaruga M; Hill E; Vandenberghe R; Fox NC; Chávez-Gutiérrez L
    Mol Psychiatry; 2022 Jun; 27(6):2821-2832. PubMed ID: 35365805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aβ43 levels determine the onset of pathological amyloid deposition.
    Tambini MD; Yin T; Yesiltepe M; Breuillaud L; Zehntner SP; d'Abramo C; Giliberto L; D'Adamio L
    J Biol Chem; 2023 Jul; 299(7):104868. PubMed ID: 37257821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.
    Ryan NS; Nicholas JM; Weston PSJ; Liang Y; Lashley T; Guerreiro R; Adamson G; Kenny J; Beck J; Chavez-Gutierrez L; de Strooper B; Revesz T; Holton J; Mead S; Rossor MN; Fox NC
    Lancet Neurol; 2016 Dec; 15(13):1326-1335. PubMed ID: 27777022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.
    Cruchaga C; Haller G; Chakraverty S; Mayo K; Vallania FL; Mitra RD; Faber K; Williamson J; Bird T; Diaz-Arrastia R; Foroud TM; Boeve BF; Graff-Radford NR; St Jean P; Lawson M; Ehm MG; Mayeux R; Goate AM;
    PLoS One; 2012; 7(2):e31039. PubMed ID: 22312439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations.
    Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC
    Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery and validation of dominantly inherited Alzheimer's disease mutations in populations from Latin America.
    Takada LT; Aláez-Verson C; Burgute BD; Nitrini R; Sosa AL; Castilhos RM; Chaves MF; Longoria EM; Carrillo-Sánchez K; Brucki SMD; Flores-Lagunes LL; Molina C; Olivares MJ; Ziegemeier E; Petranek J; Goate AM; Cruchaga C; Renton AE; Fernández MV; Day GS; McDade E; Bateman RJ; Karch CM; Llibre-Guerra JJ;
    Alzheimers Res Ther; 2022 Aug; 14(1):108. PubMed ID: 35932032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel pathogenic PSEN1 mutation in a family with Alzheimer's disease: phenotypical and neuropathological features.
    Gallo M; Marcello N; Curcio SA; Colao R; Geracitano S; Bernardi L; Anfossi M; Puccio G; Frangipane F; Clodomiro A; Mirabelli M; Vasso F; Smirne N; Muraca G; Di Lorenzo R; Maletta R; Ghidoni E; Bugiani O; Tagliavini F; Giaccone G; Bruni AC
    J Alzheimers Dis; 2011; 25(3):425-31. PubMed ID: 21422519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.
    Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O
    Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presenilin 1 and APP Gene Mutations in Early-Onset AD Families from a Southeast Region of China.
    Zhou J; Chen Y; Meng F; Zhang K; Liu X; Peng G
    Curr Alzheimer Res; 2020; 17(6):540-546. PubMed ID: 32579498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genetic screen of the mutations in the Korean patients with early-onset Alzheimer's disease.
    An SS; Park SA; Bagyinszky E; Bae SO; Kim YJ; Im JY; Park KW; Park KH; Kim EJ; Jeong JH; Kim JH; Han HJ; Choi SH; Kim S
    Clin Interv Aging; 2016; 11():1817-1822. PubMed ID: 28008242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel presenilin 1 mutation (Ile408Thr) in an Italian family with late-onset Alzheimer's disease.
    Tedde A; Bartoli A; Piaceri I; Ferrara S; Bagnoli S; Serio A; Sorbi S; Nacmias B
    Neurosci Lett; 2016 Jan; 610():150-3. PubMed ID: 26549787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase.
    Sun L; Zhou R; Yang G; Shi Y
    Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E476-E485. PubMed ID: 27930341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational analysis in familial Alzheimer's disease of Han Chinese in Taiwan with a predominant mutation PSEN1 p.Met146Ile.
    Lin YS; Cheng CY; Liao YC; Hong CJ; Fuh JL
    Sci Rep; 2020 Nov; 10(1):19769. PubMed ID: 33188256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
    De Jonghe C; Cras P; Vanderstichele H; Cruts M; Vanderhoeven I; Smouts I; Vanmechelen E; Martin JJ; Hendriks L; Van Broeckhoven C
    Neurobiol Dis; 1999 Aug; 6(4):280-7. PubMed ID: 10448055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.